Pregled bibliografske jedinice broj: 1015221
Aging and Senotherapeutics
Aging and Senotherapeutics // Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti, 537 (2019), 46-47; 16-24 doi:10.21857/moxpjhglzm (domaća recenzija, članak, ostalo)
CROSBI ID: 1015221 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Aging and Senotherapeutics
(Starenje i senoterapeutici)
Autori
Čepelak, Ivana ; Dodig, Slavica
Izvornik
Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti (1330-5301) 537
(2019), 46-47;
16-24
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
aging ; cell senescence ; senotherapeutics
(starenje ; stanična senescencija ; senoterapeutici)
Sažetak
One of the key mechanisms of the aging process of an organism and of the dysfunctionality and chronic diseases related with aging is the so-called cell senescence. It implies irreversible cell cycle arrest that occurs in response to different forms of cellular stress. Senescent cells that accumulate over time are viable, subject to phenotypic changes and excrete different soluble factors, and may affect adjacent cells, resulting in tissue and organ function disorders. Since old age is an important risk factor for many diseases, the interest of the scientific community is to reduce or avoid the effects of the aging processes. Among numerous developed therapeutic strategies, the development of senotherapeutics (i.e. the targeting strategy) has a significant place and is based on the removal of senescent cells and the abolishment of their adverse effects. Although many questions are still open, based on numerous experimental studies, it is expected that the development of senotherapeutics will contribute to the healthy life of the elderly and the treatment of specific age-related diseases.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb